RESOLVEOME
LIVE

Serial Number

97421044

Owner

BioSkryb Genomics, Inc.

Attorney

Samantha C. Markley

Filing Date

May 20, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RESOLVEOME Trademark

Serial Number: 97421044

RESOLVEOME is a trademark filed by BioSkryb Genomics, Inc. on May 20, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

BioSkryb Genomics, Inc.

2810 Meridian Parkway, Suite 110
Durham, NC 27713

Entity Type: 03

Trademark Details

Filing Date

May 20, 2022

Registration Date

Not Registered

Published for Opposition

July 18, 2023

Goods & Services

Scientific and laboratory apparatus and instruments, namely, magnetic plates for use with magnetic and paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits containing a scientific or laboratory apparatus or instrument, namely, kits comprising multi-well plates, magnetic plates, and reagents comprising paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits comprising a scientific or laboratory apparatus or instrument for the amplification and recovery of genomic material, including genomic material from single cells, and reagents for scientific or research use

Diagnostic reagents for medical use; reagents and containers specifically adapted for reagents, namely, reagents comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells, for medical purposes; diagnostic chemical test kits consisting primarily of monoclonal antibodies, buffers, and reagents for medical use; medical test kits comprised of medical diagnostic reagents and assays for high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical test kits comprised of medical diagnostic reagents for use in the amplification and recovery of genomic material, including genomic material from single cells; kits comprising reagents, namely, reagents for medical use comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells; medical test kits comprised of medical diagnostic reagents for use in connection with next-generation sequencing (NGS) for the purpose of revealing the presence and quantity of RNA and analyzing cellular transcriptome; medical test kits comprised of medical diagnostic reagents for genetic sequencing of messenger ribonucleic acid (mRNA), complementary DNA (cDNA), and full-length transcripts; diagnostic kits comprising reagents for medical use; diagnostic drug testing kits comprising reagents for drug target discovery

Assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; diagnostic reagents for clinical or medical laboratory use; reagents for scientific use; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; reagents for scientific use for use in kits for high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; reagents and containers specifically adapted for reagents, namely, reagents comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells, for research purposes; reagents and containers specifically adapted for reagents, namely, reagents for scientific use for use in the amplification and recovery of genomic material, including genomic material from single cells; chemical substances and products, namely, chemical preparations for use in genomic research; biochemicals, namely, biological reagents for use in whole genome amplification to detect genetic variants in each cell for non-medical purposes; laboratory chemicals, namely, an antibody reagent used for genomic research; chemical test kits for diagnostic purposes for laboratory and research use; diagnostic kits comprising reagents for scientific use; diagnostic kits comprised of reagents and assays for scientific use for detecting, testing, analyzing, and sequencing genes, nucleic acids, and biological molecules; medical test kits comprised of reagents for scientific use for biological analysis for use in whole genome amplification to detect genetic variants in cells; kits comprising reagents, namely, reagents for scientific use comprising paramagnetic beads for use in the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits containing assays, reagents, and chemical preparation for use in genomic research; kits containing biochemicals, namely, biological reagents for scientific use for use in whole genome amplification to detect genetic variants in each cell; laboratory apparatus and instruments, namely, chemical genomic testing kits; kits containing laboratory chemicals, namely, antibody reagents used for genomic research

Genomic analysis and sequencing services for scientific, medical, and research purposes; genomic analysis and sequencing services for precision and personalized medicine; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; medical and scientific research in connection with circulating tumor cells (CTC), cell free DNA (cfDNA), circulating tumor DNA (ctDNA), cancer genomics, methylome, methylomics, and DNA methylation; nucleic acid and ribonucleic acid analysis services for medical and scientific research purposes; providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; medical and scientific research in connection with genome amplification to detect genetic variants in cells; medical and scientific research in connection with measuring genetic diversity in single cells; medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; DNA analysis and sequencing services for scientific, medical, and research purposes; research, development and scientific consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics

Diagnostic kits and devices, namely, a cell and reagent printer in the nature of companion diagnostics (CDx); gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical and scientific purposes; scientific, medical, and laboratory apparatus and instruments, for medical purposes, for the amplification and recovery of genomic material, including genomic material from single cells, namely, cell or sample specimens that determine the heterogeneity of cellular populations within a tissue in the fields of oncology, neurology, reproductive medicine, toxicology, immunology, cardiac related tissues, and genetic engineering, namely, gene editing; medical apparatus and instruments, namely, magnetic plates for use with magnetic and paramagnetic beads for the processing, purification, and cleanup of samples containing genomic material, including material from single cells; kits containing medical and scientific apparatus, namely, cell or sample specimens that determine the heterogeneity of cellular populations within a tissue in the fields of oncology, neurology, reproductive medicine, toxicology, immunology, cardiac related tissues, and genetic engineering, namely, gene editing for use in genetic research for medical purposes

Medical testing for diagnostic or treatment purposes; medical testing for precision and personalize medicine purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services; medical analysis services for diagnosis the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; medical analysis services for diagnosis in the field of gene therapy and cell therapy; medical analysis services for diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2026 REAP
SOU TEAS EXTENSION RECEIVED
Mar 10, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 17, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 17, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 17, 2026 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 2, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 2, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 8, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 7, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 11, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 11, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 11, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 11, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 12, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 12, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 12, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2022 NWOS
NEW APPLICATION ENTERED
May 24, 2022 NWAP